Validated Sensitive Spectrophotometric methods for Determination of Carvedilol and Nebivolol HCl in dosage forms.

Authors

  • Fawzia Ibrahim University of Mansoura, 35516, Mansoura
  • Nahed M El-Enany University of Mansoura, 35516, Mansoura
  • Shereen Shalan University of Mansoura, 35516, Mansoura

DOI:

https://doi.org/10.24297/jac.v10i6.6667

Keywords:

Carvedilol, Nebivolol HCl, spectrophotometry, Eosin Y, dinitrofluorobenzene

Abstract

A simple, sensitive and rapid spectrophotometric methods were developed and validated for the determination of two antihypertensive drugs namely, carvedilol and nebivolol hydrochloride in pure form and pharmaceutical formulations. Method (I) is based on the formation of a binary complex between the studied drugs and eosin Y in presence of tween 80 at (pH 3.0).The formed complex exhibited maximum absorption at 545 nm for carvedilol and 543 nm for nebivolol. The concentration plots were rectilinear over concentration range of 0.5-5 and 1-7 µg/mL with lower detection limits of 0.09 and 0.11µg/mL and lower quantitation limits of 0.28 and 0 .34 µg/mL for carvedilol and nebivolol respectively. Method (II) is based on the reaction of studied drugs through their secondary amino groups with 2, 4-dinitrofluorobenzene (DNFB) at pH 8 to form yellow colored reaction products peaking at 383 nm and 390 nm for carvedilol and nebivolol, respectively. The absorbance-concentration plots were rectilinear over the concentration ranges of 5-30 and 4-28 µg/ mLwith the lower detection limits of 0.48 and 0.51 µg/mL and the lower quantitation limits of 1.45 and 1.54 µg/mL for cavredilol and nebivolol respectively. The different experimental parameters affecting the development and stability of the formed complex and reaction products were carefully studied and optimized for both methods. Both methods were successfully applied for determination of the studied drugs in their dosage forms.

Downloads

Download data is not yet available.

References

[1] Sweetman, S.C. (Ed) (2009) Martindale: The Complete Drug Reference, 36th ed., The Pharmaceutical Press, London.
[2] The United States Pharmacopoeia 30, the National Formulary 25, and US Pharmacopeial Convention: Rockville, MD, (2007); Electronic version.
[3] LAKSHMANA RAO, A.; RAJESWARI, K.R. G.G. 2010. E-J.Chem. 7(2), 445-448.
[4] Murali, D.; Neeharika, T.; Rambabu, C. 2013. Asian J.Chem. 25(6), 2981-2984.
[5] Sharma, T.,Patra, R.,Sankar, D. G., Si, S. C. 2012 Asian J.Pharma. Clini.Res. 5(Suppl. 4), 69-72.
[6] Murali, D., Venkata Rao, S. V., Malleswara Rao, N. V. N., Rambabu, C. 2011. J.Pharm. Res. (2011), 4(12), 4455-4457, 3 pp.
[7] Zhao, G., Shao, Z.,Du, S. 2011. Hainan Yixueyuan Xuebao , 17(12), 1708-1710.
[8] Patel, S. R., Patel, S. M.,Patel, J. I.,Patel, P. U. 2011. Res.J.Pharm.Tech.,4(1), 109-112.
[9] Malipatil, S. M., Deepthi, M., Patil, S. K., Jahan, K. 2011. Inter. J.Pharm. Pharmac.Sci.3(1), 13-15.
[10] Malipatil, S. M., Deepthi, M., Patil, S. K., Sarsambi, P. S. 2010. Inter.J.Chem.Sci. , 8(3), 1457-1463.
[11] Parambi, D. G. T.,Mathew, M.Sr.,Jose, A.R.K. G. 2010. Inter. J.Pharmac.Sci. Rev. Res.3(2), 139-141.
[12] Rao, A. L.,Rajeswari, K. R.; Sankar, G. G. 2010. J.Chem.Pharmac.l Res.,2(1), 280-282.
[13] Onal, A. 2011 Quimica Nova , 34(4), 677-682.
[14] Sankar, G. G.,Rajeswari, K. R., Rao, A. La., Rao, J. V. L. N. S.(2005). Acta Ciencia Indica, Chem. , 31(3), 175-178.
[15] Kachhadia, P. K., Doshi, A. S., Joshi, H. S.(2008). J. AOAC Inter. , 91(3), 557-561.
[16] Ieggli, C. V.S.,Cardoso, Simone G.,Belle, L.P.2005. J.AOAC Inter., 88(5), 1299-1303.
[17] Desai, D. C.; Karkhanis, V. V. Int.l Res. J.Pharm. (2012), 3(2), 114-116.
[18] Shetty, D. N.; Narayana, B. ISRN Spectroscopy (2012), 373215, 6 pp.
[19] Bhange, P.; Kotolkar, P.; Mehere, A. Int. J.Pharm. Res.Bio-Sci. (2013), 2(1), 342-348.
[20] Ansary, A.; Abdel-Moety, M. M.; Abdel-Gawad, F. M.; Mohamed, E. A.; Khater, M. Pharm. Anal.Acta (2012), 3(9), 1000186/1-1000186/6.
[21] Onal, A. Quimica Nova (2011), 34(4), 677-682.
[22] Xu, Li X.,Hui, N., Ma, Li Y.,Wang, H.Y.2005. Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy, 61A(5), 855-859.
[23] Zhou, Zhen; Ge, Q.,Zhi, X.,Ma, Lili; Li, X.2004. Zhongguo Yiyao Gongye Zazhi , 35(11), 667-669.
[24] Meng, F.,Feng, X.,Liu, Y.,Wang, L.2006. Zhongguo Yiyuan Yaoxue Zazhi (2006), 26(6), 702-704.
[25] Patel, L. J., Suhagia, B. N., Shah, P. B., Shah, R. R.2006. Indian J.Pharmac. Sci. , 68(6), 790-793.
[26] Gu, Sh.,Xiao, Z.,Dai, Z.,Chen, H.2004. Zhongguo Yaoke Daxue Xuebao 35(1), 54-56.
[27] Carmo Borges, N. C.,Duarte Mendes, G.,De Oliveira Silva, D.,Marcondes Rezende, V.2005. J.Chrom. B: Anal.Tech. Biom.Life Sci., 822(1-2), 253-262.
[28] El-Enany N.2004. IL Farmaco, 59: 63-69.
[29] El- Brashy AM.,Metwally MES, El- Sepai FA.2004. IL Farmaco , 59: 809-817.
[30] Ramadan,A.A.;Mandil,H.2006.Anal.Biochem,353:133-137.
[31] Ayad M A, Shalaby A A , Abdellatef H E, Hosny M M. (2002) J. Pharm. Biomed. Anal. 28: 311-321.
[32] Walash MI, Rizk MS, Eid MI, Fathy ME.2007. J. AOAC International , 90: 1579-1587.
[33] Omar MA. J.2009. Fluorescence, 20: 275-281.
[34] K.A. Conner, Reaction Mechanisms in Organic Analytical Chemistry, Wiley, New York, 1973, 274.
[35] Darwish, I. A., Al-Shehri, M. M. & El-Gendy, M. A. (2012) Chem Centr J 6-11.
[36] Walash, M. I., Belal, F. F., El-Enany, N. M. & El-Maghrabey, M. H. (2011) Chem Centr J. 5:36,1-10.
[37] Britton, H.T.S,Hydrogen,Ions,chapman and Hall,London, 4thedu,1952,p 313.
[38] ICH Harmonized Tripartite Guideline, Validation of analytical procedures: Text and Methodology, Q2(R1), Current Step 4 Version, Parent Guidelines on Methodology Dated November 6 1996, Incorporated in November 2005. http://www.bioforum.org.il/Uploads/Editor/karen/q2_r1_step4.pdf.
[39] Miller, J. N. & Miller, J. C. (2005) Statistics and chemometrics for Analytical Chemistry, 5th ed. Prentice Hall, England, p. 256.
[40] Rose, J. (1964) Advanced Physico-Chemical experiments. Pitaman, London, p. 67.

Downloads

Published

2014-09-30

How to Cite

Ibrahim, F., El-Enany, N. M., & Shalan, S. (2014). Validated Sensitive Spectrophotometric methods for Determination of Carvedilol and Nebivolol HCl in dosage forms. JOURNAL OF ADVANCES IN CHEMISTRY, 10(6), 2796–2813. https://doi.org/10.24297/jac.v10i6.6667

Issue

Section

Articles